ADVERTISEMENT


Members Only The content below is member only

Medicare cancels Part B drug payment model in response to MGMA advocacy

Summary:

The Centers for Medicare & Medicaid Services (CMS) withdrew its proposal to change the way Medicare pays for drugs administered in physician offices. MGMA raised significant concerns regarding the proposed payment model, which would have reduced Medicare reimbursement without addressing the root cause of drug price increases set by the manufacturer.

To access the full content, select an option below.

 

Member Login Not a member? Start a free trial

 

Contact Information

Contact Congress Contact Congress

Login


Not a Member?

Members have the opportunity to interact directly with the MGMA Government Affairs staff. 

Sign up for a 30-day MGMA trial!


Benefits of becoming an MGMA member:

  • Weekly Washington Connection e-newsletter
  • Access to expert Government Affairs staff
  • Timely resources and articles